For the Inventor, By the Inventor

Enter assignee name

Anaeropharma Science, Inc.

USPTO Granted Patents = 13

CIPO Patents = 33

EPO Patents = 8

Forward Citations = 50

Loading Chart...

Loading Chart...

55 inventors (with patents filed for the assignee):

Takayuki Sasaki (7 out of 104 patents)

Yuko Shimatani-Shibata (5 out of 5 patents)

Minoru Fujimori (5 out of 5 patents)

4. Shun'ichiro Taniguchi (5 out of 5 patents)

5. Yuko Shimatani (4 out of 4 patents)

6. Hitomi Shimizu (4 out of 5 patents)

7. Jun Amano (4 out of 7 patents)

8. Takeshi Masaki (3 out of 4 patents)

9. Hitomi Shimizu-Matsuhashi (3 out of 3 patents)

10. Yoshinori Hamaji (3 out of 3 patents)

11. Hiromi Yonekura (3 out of 3 patents)

12. Yuko Wada (2 out of 2 patents)

13. Koichi Koseki (2 out of 2 patents)

14. Koichiro Shioya (2 out of 2 patents)

15. Satoshi Kobayashi (2 out of 19 patents)

13 patents: Sort by Forward Citations

1. 10993972 - Therapeutic agent for ischemic diseases (2021-05-04),

2. 10563208 - Co-expression plasmid (2020-02-18),

3. 10443061 - Heterologous polypeptide expression cassette (2019-10-15),

4. 9730968 - Therapeutic agent for ischemic diseases (2017-08-15),

5. 9228191 - Transfection vector (2016-01-05),

6. 8911721 - Method of constructing gene transport support (2014-12-16),

7. 8734779 - 5-fluorouracil-resistant bacteria and method for production thereof (2014-05-27),

8. 8535939 - Transfection vector (2013-09-17),

9. 8470311 - Therapeutic agent for anaerobic diseases (2013-06-25),

10. 8383398 - Expression vector (2013-02-26),

11. 8338162 - Obligately anaerobic mutant lactic acid bacterium and preparation method therefor, and expression vector functioning in obligately anaerobic lactic acid bacterium (2012-12-25),

12. 8021653 - [object Object] (2011-09-20),

13. 7740835 - Anaerobic bacterium as a drug for cancer gene therapy (2010-06-22),

Anaeropharma Science, Inc. is a biopharmaceutical company focused on developing and commercializing novel cancer treatments. They specialize in utilizing proprietary technologies to exploit the unique microenvironment of solid tumors, targeting anaerobic bacteria to deliver anti-cancer agents directly to tumor tissues. Their innovative approach aims to enhance the efficacy and reduce the toxicity of cancer therapies.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

13 Patents

#1,455 in Tokyo

#3,655 in Japan

#43,615 in the World

Anaeropharma Science, Inc.

Forward Citations = 50

55 inventors:

Takayuki Sasaki (7 out of 104 patents)

Yuko Shimatani-Shibata (5 out of 5 patents)

Minoru Fujimori (5 out of 5 patents)

4. Shun'ichiro Taniguchi (5 out of 5 patents)

5. Yuko Shimatani (4 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…